人工甜味剂通过改变肠道微生物群来诱导葡萄糖不耐受
Jotham Suez1, Tal Korem2, David Zeevi2
1Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Nature
|September 19, 2014
概括
非热量的人造甜味剂 (NAS) 通过改变肠道微生物群,可以对葡萄糖耐受性产生负面影响. 这些效应在小鼠和人类中观察到,这表明需要重新评估广泛的NAS使用.
科学领域:
- 微生物学 微生物学
- 代谢科学 代谢科学
- 食品科学 食品科学 食品科学
背景情况:
- 无热量人工甜味剂 (NAS) 是全球普遍存在的食品添加剂.
- 尽管使用广泛,但关于NAS安全性和代谢效应的科学证据仍然有限和有争议.
研究的目的:
- 为了研究NAS消费对葡萄糖不耐受性的影响.
- 探索肠道微生物群在调解NAS诱导的代谢变化的作用.
主要方法:
- 用小鼠模型来评估NAS消费后的葡萄糖不耐受性.
- 用抗生素治疗和便微生物群移植 (FMT) 来确定微生物群的参与.
- 通过NAS改变的代谢途径被确定.
- 包括健康的人类受试者来评估NAS的影响.
主要成果:
- 通过改变肠道微生物群的组成和功能,NAS消费在小鼠中诱导了葡萄糖不耐受.
- 纳斯诱导的代谢功能障碍可以通过FMT转移,并通过抗生素逆转.
- 特定的NAS改变的微生物通路与代谢性疾病易感性有关.
- 在人类受试者中观察到类似的NAS诱导的功能失调和葡萄糖不耐受.
结论:
- 消费NAS可以通过肠道失调导致葡萄糖不耐受.
- 这些发现将NAS,微生物群变化和代谢异常联系在一起.
- 需要重新评估广泛使用NAS的情况.
更多相关视频
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
9.3K
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
70.0K
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
945
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
945
Glucose Absorption Into the Small Intestine
33.9K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
33.9K
Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
984
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
984
Glucose Transporters
15.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.1K
Overview of Carbohydrate Metabolism
4.4K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K
